"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 11 | 11 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 16 | 16 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 20 | 20 |
| 2003 | 0 | 22 | 22 |
| 2004 | 0 | 36 | 36 |
| 2005 | 0 | 35 | 35 |
| 2006 | 0 | 48 | 48 |
| 2007 | 1 | 36 | 37 |
| 2008 | 0 | 40 | 40 |
| 2009 | 3 | 52 | 55 |
| 2010 | 3 | 46 | 49 |
| 2011 | 3 | 50 | 53 |
| 2012 | 2 | 57 | 59 |
| 2013 | 2 | 49 | 51 |
| 2014 | 4 | 54 | 58 |
| 2015 | 5 | 60 | 65 |
| 2016 | 3 | 51 | 54 |
| 2017 | 7 | 56 | 63 |
| 2018 | 10 | 65 | 75 |
| 2019 | 4 | 58 | 62 |
| 2020 | 4 | 49 | 53 |
| 2021 | 5 | 37 | 42 |
| 2022 | 0 | 22 | 22 |
| 2023 | 0 | 34 | 34 |
| 2024 | 7 | 10 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2024 Nov 15; 210(10):1210-1218.
-
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease. Inflamm Bowel Dis. 2024 Nov 04; 30(11):2064-2075.
-
Regulatory roles of NAMPT and NAD+ metabolism in uterine leiomyoma progression: Implications for ECM accumulation, stemness, and microenvironment. Redox Biol. 2024 Dec; 78:103411.
-
Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B). Ann Neurol. 2024 Dec; 96(6):1092-1103.
-
Updating and calibrating the Real-World Progression In Diabetes (RAPIDS) model in a non-Veterans Affairs population. Diabetes Obes Metab. 2024 Nov; 26(11):5261-5271.
-
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes. Nat Genet. 2024 Sep; 56(9):1878-1889.
-
Unique Lessons From the Natural Progression of Rejection in Human Uterine Allografts. Clin Transplant. 2024 Aug; 38(8):e15434.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1182-1200.
-
Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Am J Respir Crit Care Med. 2024 07 01; 210(1):108-118.
-
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications. Br J Cancer. 2024 Aug; 131(3):589-600.